Tsung Hung (Max) Li, Ph.D.
About Tsung Hung (Max) Li, Ph.D.
Tsung Hung (Max) Li, Ph.D. serves as the Senior Director of CMC Regulatory Affairs at Insmed Incorporated, a position he has held since 2018 in Bridgewater, New Jersey.
Work at Insmed
Tsung Hung (Max) Li, Ph.D., serves as the Senior Director of CMC Regulatory Affairs at Insmed Incorporated. He has held this position since 2018, contributing to the company's regulatory strategies and compliance in the development of pharmaceutical products. His role involves overseeing the chemistry, manufacturing, and controls (CMC) aspects of regulatory submissions, ensuring that products meet the required standards for safety and efficacy. Insmed is located in Bridgewater, New Jersey, where Li has been instrumental in navigating complex regulatory landscapes.
Education and Expertise
Tsung Hung (Max) Li, Ph.D., possesses a strong educational background that supports his role in regulatory affairs. His expertise lies in the field of chemistry and regulatory compliance, equipping him with the necessary skills to manage CMC-related activities. His academic qualifications and professional experience contribute to his ability to effectively lead regulatory initiatives at Insmed.
Background
Tsung Hung (Max) Li, Ph.D., has a professional background that includes significant experience in regulatory affairs, particularly in the pharmaceutical industry. Since joining Insmed in 2018, he has focused on the intersection of manufacturing processes and regulatory requirements, playing a key role in the development of new therapies. His work is characterized by a commitment to maintaining high standards in product development and regulatory compliance.
Achievements
During his tenure at Insmed, Tsung Hung (Max) Li, Ph.D., has contributed to various regulatory submissions and initiatives that align with the company's mission to provide innovative therapies. His leadership in CMC Regulatory Affairs has facilitated the advancement of product development processes, ensuring compliance with regulatory standards. Specific achievements include successful navigation of complex regulatory pathways, although detailed examples are not provided.